New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatment

The Lancet Neurology · Published 2026-05-14 · DOI 10.1016/s1474-4422(26)00090-6

Authors (8)

Elisa Menozzi, Marco Toffoli, Michela Deleidi, Donato A Di Monte, Fabio Blandini, Dimitri Krainc, Ellen Sidransky, Anthony H V Schapira

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Menozzi, E., Toffoli, M., Deleidi, M., et al. (2026). New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatment. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(26)00090-6

Related articles